Related Experiment Video
Updated: May 28, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Anti-inflammatory potential of probiotics: lipoteichoic acid makes a difference
Sarah Lebeer1, Ingmar J J Claes, Jos Vanderleyden
1Centre of Microbial and Plant Genetics, K.U. Leuven, Kasteelpark Arenberg 20, Box 2460, B-3001 Leuven, Belgium. sarah.lebeer@biw.kuleuven.be
Abstract:
Lipoteichoic acid (LTA) mutants of lactobacilli suppress inflammation in animal models of experimental colitis. The fact that a single mutation of an administered Lactobacillus strain can result in enhanced probiotic efficacy is surprising given the genetic diversity and complexity of the intestinal niche, but at the same time exciting from a microbiological, immunological and gastroenterological point of view. In this Opinion article, we discuss the possible impacts of LTA modification in probiotic bacteria in the context of the current knowledge regarding the proinflammatory capacity of LTA, structure-activity relationships of LTA, intestinal LTA recognition in healthy and colitis conditions and anti-inflammatory molecules of lactobacilli.
Related Concept Videos
Probiotics
Formation of Lipopolysaccharides
Microbiota Modulation by Antibiotics
Biosynthesis of Lipids
Dysbiosis of the Gut Microbiota
Functions of the Gut Microbiota
